Tetanus Antibody, IgG
Also known as: TETANUS
Use
Evaluate the ability of a patient to produce antibodies to pure protein vaccine after vaccination to rule out antibody deficiency. The test measures the IgG antibody concentration to determine responder status based on the difference in antibody levels before and after immunization with tetanus vaccine.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration.
New York Approved
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Tetanus IgG
Protein
LOINC Codes
- 53935-3 - C tetani Toxoid IgG SerPl IA-aCnc
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect in serum separator tube. Post specimen should be drawn 30 days after immunization. Separate serum from cells ASAP or within 2 hours of collection.
Causes for Rejection
Plasma or other body fluids. Contaminated, hemolyzed, or severely lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year (avoid repeated freeze/thaw cycles) |
Other tests from different labs that may be relevant